Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1528, 2006-01, pp. : 14-14
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Role of oxaliplatin in colorectal cancer
Inpharma, Vol. 1, Iss. 1227, 2000-01 ,pp. :
Access to resources
Recommend
Oxaliplatin: In Operable Colorectal Cancer
By Keam Susan J. Dunn Christopher J. Figgitt David P.
Drugs, Vol. 65, Iss. 1, 2005-01 ,pp. :
XELOX dominant over FOLFOX4 for colorectal cancer
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 585, 2009-01 ,pp. :
FOLFOX4: clear benefit in colorectal cancer
Inpharma, Vol. 1, Iss. 1347, 2002-01 ,pp. :
FOLFOX4 feasible first-line therapy for advanced gastric cancer
Inpharma, Vol. 1, Iss. 1498, 2005-01 ,pp. :